378 related articles for article (PubMed ID: 30916822)
1. Clinical and radiological outcomes of infantile hemangioma treated with oral propranolol: A long-term follow-up study.
Yu Z; Cai R; Chang L; Qiu Y; Chen X; Chen Q; Ma G; Jin Y; Lin X
J Dermatol; 2019 May; 46(5):376-382. PubMed ID: 30916822
[TBL] [Abstract][Full Text] [Related]
2. Sequelae following infantile haemangiomas treated with propranolol.
Baselga E; El Hachem M; Diociaiuti A; Carnevale C; Downey C; Roe E; Mascaro P; Neri I; Leuzzi M; Bernabeu-Wittel J; Monserrat-García MT; Ortiz-Prieto A; Torrelo A; Knopfel N; Vercellino N; Manunza F; Oranges T; Bassi A; Gonzalez-Enseñat MA; Vicente A; Gich I; Puig L
Eur J Dermatol; 2021 Dec; 31(6):785-790. PubMed ID: 35107070
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors for Degree and Type of Sequelae After Involution of Untreated Hemangiomas of Infancy.
Baselga E; Roe E; Coulie J; Muñoz FZ; Boon LM; McCuaig C; Hernandez-Martín A; Gich I; Puig L
JAMA Dermatol; 2016 Nov; 152(11):1239-1243. PubMed ID: 27540637
[TBL] [Abstract][Full Text] [Related]
4. Propranolol treatment for infantile hemangioma: a case series of sixty-two patients.
Stringari G; Barbato G; Zanzucchi M; Marchesi M; Cerasoli G; Tchana B; Gritti A; Boccaletti V; Lombardi AA; Carano N
Pediatr Med Chir; 2016 Jun; 38(2):113. PubMed ID: 27345601
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases.
Sagi L; Zvulunov A; Lapidoth M; Ben Amitai D
Dermatology; 2014; 228(2):136-44. PubMed ID: 24556822
[TBL] [Abstract][Full Text] [Related]
6. Propranolol in a case series of 174 patients with complicated infantile haemangioma: indications, safety and future directions.
Hermans DJ; Bauland CG; Zweegers J; van Beynum IM; van der Vleuten CJ
Br J Dermatol; 2013 Apr; 168(4):837-43. PubMed ID: 23278381
[TBL] [Abstract][Full Text] [Related]
7. A 7-year follow-up study on untreated deep or mixed facial infantile hemangioma in East-Asian patients: When propranolol was not yet an option.
Chang SJ; Qiao C; Chang L; Gao W; Jin Y; Ma G; Qiu Y; Lin X
J Dermatol; 2019 Nov; 46(11):962-966. PubMed ID: 31515846
[TBL] [Abstract][Full Text] [Related]
8. Thirty-two Japanese cases of infantile hemangiomas treated with oral propranolol.
Kagami S; Kaneko M; Katori T
J Dermatol; 2018 Jun; 45(6):719-722. PubMed ID: 29603774
[TBL] [Abstract][Full Text] [Related]
9. Clinical features of cutaneous infantile hemangioma combined with asymptomatic infantile hepatic hemangioma and efficacy of propranolol treatment.
Li L; Yu L; Xu Z; Wei L; Zhang B; Han X; Sun Y; Ma L
J Cosmet Dermatol; 2023 Dec; 22(12):3369-3374. PubMed ID: 37313653
[TBL] [Abstract][Full Text] [Related]
10. Location of infantile hemangioma is a predictor of volumetric sequelae after involution.
Chang SJ; Yu W; Gu Y; Han Y; Shang Y; Chang L; Jin Y; Ma G; Qiu Y; Lin X
J Dermatol; 2019 May; 46(5):371-375. PubMed ID: 30888067
[TBL] [Abstract][Full Text] [Related]
11. Propranolol: useful therapeutic agent for the treatment of ulcerated infantile hemangiomas.
Kim LHC; Hogeling M; Wargon O; Jiwane A; Adams S
J Pediatr Surg; 2011 Apr; 46(4):759-763. PubMed ID: 21496551
[TBL] [Abstract][Full Text] [Related]
12. Prolonged growth of infantile hemangioma after pulsed dye laser and oral propranolol treatment.
Kagami S; Kaneko M; Kishi A; Katori T
J Dermatol; 2018 Sep; 45(9):1109-1112. PubMed ID: 29952019
[TBL] [Abstract][Full Text] [Related]
13. Oral propranolol for infantile hemangiomas beyond the proliferative phase.
Kagami S; Katori T
J Dermatol; 2018 Oct; 45(10):1199-1202. PubMed ID: 30051930
[TBL] [Abstract][Full Text] [Related]
14. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
J Cutan Med Surg; 2012; 16(5):317-23. PubMed ID: 22971306
[TBL] [Abstract][Full Text] [Related]
15. Clinical and Radiological Evaluation of Periocular Infantile Hemangioma Treated With Oral Propranolol: A Case Series.
Ginguerra MA; Saito O; Fernandes JBVD; Castro DS; Matayoshi S
Am J Ophthalmol; 2018 Jan; 185():48-55. PubMed ID: 29103963
[TBL] [Abstract][Full Text] [Related]
16. Safety and effectiveness of oral propranolol for infantile hemangiomas started before 5 weeks and after 5 months of age: an Italian multicenter experience.
El Hachem M; Gesualdo F; Diociaiuti A; Berti I; Vercellino N; Boccaletti V; Neri I; Porcedda G; Greco A; Carnevale C; Oranges T; Cutrone M; Dalmonte P
Ital J Pediatr; 2017 Apr; 43(1):40. PubMed ID: 28424095
[TBL] [Abstract][Full Text] [Related]
17. Long-term treatment with oral propranolol reduces relapses of infantile hemangiomas.
Giachetti A; Garcia-Monaco R; Sojo M; Scacchi MF; Cernadas C; Guerchicoff Lemcke M; Dovasio F
Pediatr Dermatol; 2014; 31(1):14-20. PubMed ID: 24283619
[TBL] [Abstract][Full Text] [Related]
18. Oral propranolol: an effective, safe treatment for infantile hemangiomas.
Zaher H; Rasheed H; Hegazy RA; Hegazy RA; Abdelhalim DM; Gawdat HI
Eur J Dermatol; 2011; 21(4):558-63. PubMed ID: 21697036
[TBL] [Abstract][Full Text] [Related]
19. A study of 95 infantile hemangiomas treated with propranolol: A potentially efficacious combination with laser therapy.
Yamada-Kanazawa S; Shimada S; Nakayama W; Sawamura S; Nishimura Y; Kajihara I; Makino K; Aoi J; Masuguchi S; Amano F; Fukushima S
Drug Discov Ther; 2023 Mar; 17(1):70-72. PubMed ID: 36843077
[TBL] [Abstract][Full Text] [Related]
20. Propranolol therapy for infantile hemangioma: our experience.
Zhang L; Wu HW; Yuan W; Zheng JW
Drug Des Devel Ther; 2017; 11():1401-1408. PubMed ID: 28507428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
